Press release
Umbilical Cord Blood Banking Market to Garner USD 19,335.6 million by 2020
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/3043
The UCB banking market is witnessing a significant growth due to the increasing prevalence of chronic diseases coupled with regenerative medicines. In addition, initiatives by various government associations have increased the importance of UCB by rising awareness about potential applications of cord blood are also supporting in the growth of the global UCB banking market.
However, strict license and accreditation procedures and high cord blood banking fee in private banks hampers the growth of global UCB banking market. As a result, the global UCB banking market is expected to grow a CAGR of 6.1% during 2014-2020.
North America has the largest market for UCB banking. Increasing prevalence of chronic diseases is key driver of UCB banking market in the region. In addition, various government associations have also led to the importance of cord blood donation and services for its future use in North America.
Request for Report Methodology @: https://www.persistencemarketresearch.com/methodology/3043
Similarly, the European UCB banking market is mainly driven by the increasing prevalence of diseases. In addition, increased awareness about therapeutic applications of cord blood and rising number of live births are also contributing in the growth of the UCB market in the region.
In Asia-Pacific, UCB banking market is growing due to rising aging population and increasing prevalence of chronic diseases. In addition, several government associations and increasing number of live births are also increasing the demand of cord blood banking services in the region.
Cord Blood Registry Systems, Inc, Cordlife Group Limited, Cord Blood America, Inc. Cryo-Cell International, Inc., China Cord Blood Corporation and Esperite NV are some of the leading players in the global UCB banking market. Other major players of UCB banking market include Smart Cells International Ltd, StemCyte, ViaCord and NeoStem Inc.
Browse the full Global Market Study on UCB Banking - Asia-Pacific to Witness Highest Growth by 2020 report at https://www.persistencemarketresearch.com/market-research/umbilical-cord-blood-banking-market.asp
The global UCB banking market is segmented as follows:
UCB Banking Market, By Therapeutic Application of UCB
Leukemia
Bone Marrow Failure Syndromes
Metabolic/Storage Diseases
Lymphoma
Immune Deficiencies
UCB Banking Market, By Storage Option
Private UCB Bank
Public UCB Bank
UCB Banking Market, by Geography
North America
The U.S.
Canada
Rest of North America
Europe
The U.K.
France
Germany
Spain
Italy
Belgium
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Singapore
Rest of Asia-Pacific
Rest of the World (RoW)
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Umbilical Cord Blood Banking Market to Garner USD 19,335.6 million by 2020 here
News-ID: 1592197 • Views: …
More Releases from Persistence Market Research
Libya Dialysis Machines Market to Reach US$ 966.2 Mn by 2032, Growing at 4% CAGR
The dialysis equipment sector in Libya has entered a compelling growth phase. At the close of 2021, the Libya dialysis machines market was valued at US $467.8 million. Over the next decade, this market is projected to expand at a CAGR of 4%, ultimately reaching an estimated US $966.2 million by 2032.
Request a Sample: https://www.persistencemarketresearch.com/samples/33153
Key Growth Drivers
Several factors are stimulating demand for dialysis machines across Libya's healthcare sector:
Rising Prevalence of…
Endoscopic Spinal Surgery Market to Reach US$ 1.5 Bn by 2032, Expanding at 7.9% …
The global market for endoscopic spinal surgery is poised for remarkable growth in the coming years. According to a new analysis by Persistence Market Research, the market is expected to expand from approximately US$ 745.4 million in 2025 to around US$ 1,504.2 million by 2032, representing a compound annual growth rate (CAGR) of 7.9 % over the 2025-2032 period.
Request a Sample: https://www.persistencemarketresearch.com/samples/19993
Market Overview & Growth Drivers
The strong projected growth of…
Medical Hyperspectral Imaging Market to Reach US$ 313.3 Mn by 2032, Registering …
The global market for medical hyperspectral imaging (MHSI) is poised for robust expansion, with the total market size expected to grow from approximately US$ 214.4 million in 2025 to US$ 313.3 million by 2032, representing a compound annual growth rate (CAGR) of 13.1 % over the period 2025-2032.
Request a Sample: https://www.persistencemarketresearch.com/samples/35072
What is Medical Hyperspectral Imaging?
Hyperspectral imaging involves capturing data across large numbers of narrow and contiguous spectral bands - far…
Hearing Aids Market to Reach US$ 13.5 Bn by 2032 | CAGR 7.7% Growth Forecast
Hearing Aids Market Outlook
The global hearing aids market is poised for robust growth, driven by a convergence of demographic shifts, technology innovation, and changing healthcare access. With the market valued at approximately US$ 8.0 billion in 2025 and forecast to reach around US$ 13.5 billion by 2032, it is projected to expand at a compound annual growth rate (CAGR) of about 7.7% from 2025 to 2032.
Request a Sample: https://www.persistencemarketresearch.com/samples/4414
Key Growth…
More Releases for UCB
Epilepsy Market Expected to Gain Momentum Through 2034, According to DelveInsigh …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Epilepsy Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveI …
The Key Epilepsy Companies in the market include - Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences, and others.
DelveInsight's "Epilepsy Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Epilepsy, historical and forecasted epidemiology as well as the Epilepsy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom…
Fibromyalgia Market to Exhibit Rapid Growth Rate During the Forecast Period (202 …
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Fibromyalgia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Fibromyalgia Market Forecast
https://www.delveinsight.com/sample-request/fibromyalgia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the key facts of the Fibromyalgia…
Anticonvulsant Market - Functional Survey 2025 | GlaxoSmithKline Inc., UCB Group
Anticonvulsant Market for Fibromyalgia: Snapshot
Anticonvulsants are pharmacological agents from a diverse group that are used for the treatment of epileptic seizures. Anticonvulsants are increasingly in demand on account of their use for the treatment of bipolar disorders. They are also used for the treatment of borderline personality disorder. Anticonvulsants act as stabilizers of mood and helps in the treatment of neuropathic pain. They suppress the rapid, excessive firing of neurons…
Epilepsy Drugs Market 2017- UCB, EISAI, Pfizer
Epilepsy Drugs Market is likely to reach nearly USD 5.5 Billion by the year end of 2021.
Market growth can be attributed to factors such as rising incidence of neurological disorders, growing disease awareness, introduction of novel antiepileptic drugs (AEDs), strong government support and initiatives. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs, concerns over decreasing…
Global Stem Cell UCB Market Research Report 2016
Global Stem Cell UCB Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The market intelligence publication delves into the condition of the global Stem Cell UCB market. An in-depth examination of the existing market state, past progress, and forthcoming prospects of the global Stem Cell UCB market has been presented in the research report. The research publication also reports…
